A calmodulin antagonist has no effect on the repair of X-ray-induced damage in a murine mammary carcinoma cell line.
The effects of the calmodulin antagonist W13 were determined on potentially lethal damage repair, sublethal damage repair, and X-ray-induced DNA damage repair following X irradiation of 67 murine mammary carcinoma cells in the proliferative and quiescent states. Studies with W13 (20 micrograms/ml) on proliferating cells showed that the cells rounded up within 2 h but stayed attached to the dishes and there was a slight transient G2 block by 6 h. Also, the proportion of S-phase cells at 12 h was reduced to 65% of control with the concurrent [3H]thymidine incorporation reduced to 62% of control. There was no detectable effect from this pharmacological dose of W13 either on PLDR in proliferating cells at 400 and 800 rad or on quiescent cells at 200 and 400 rad. Likewise, there was no measurable effect on SLDR in either proliferating or quiescent cells at equally split doses of 800 and 600 rad, respectively. In addition, for control vs W13-treated proliferating cells, no difference was detected either in the induction of DNA damage by X irradiation or in the initial rate of repair (T 1/2 approximately equal to 7 min), as measured by the alkaline filter elution assay. In contrast to uv and bleomycin-induced damage, these data suggest that calmodulin may have no major role in either the molecular or cellular recovery from X-ray-induced damage in mammalian cells.
D000818:Animals; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D002460:Cell Line; D004260:DNA Repair / Q000187:drug effects*; D004273:DNA, Neoplasm / Q000528:radiation effects*; D066298:In Vitro Techniques; D008325:Mammary Neoplasms, Experimental / Q000235:genetics*; D051379:Mice; D011831:Radiation Genetics; D013449:Sulfonamides / Q000494:pharmacology*
D002147:Calmodulin; D004273:DNA, Neoplasm; D013449:Sulfonamides; C033772:N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide